UBS Maintains a 'Neutral' on SXC Health Solutions (SXCI); The Story Just Keeps Getting Better
Tweet Send to a Friend
UBS maintains a 'Neutral' on SXC Health Solutions (Nasdaq: SXCI), raises PT from $37 to $40.
UBS analyst says, "On ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "On ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
